These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35940204)

  • 1. Hormone- and antibody-mediated activation of the thyrotropin receptor.
    Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
    Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody mimicry of hormone action at the thyrotropin receptor.
    Faust B; Billesbølle CB; Suomivuori CM; Singh I; Zhang K; Hoppe N; Pinto AFM; Diedrich JK; Muftuoglu Y; Szkudlinski MW; Saghatelian A; Dror RO; Cheng Y; Manglik A
    Nature; 2022 Sep; 609(7928):846-853. PubMed ID: 35940205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
    Hamidi S; Chen CR; McLachlan SM; Rapoport B
    Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
    Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
    Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
    Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
    Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
    Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
    Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
    Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Action of TSHR Autoantibodies.
    Furmaniak J; Sanders J; Núñez Miguel R; Rees Smith B
    Horm Metab Res; 2015 Sep; 47(10):735-52. PubMed ID: 26361260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
    Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
    Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
    Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
    J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
    McLachlan SM; Aliesky HA; Rapoport B
    Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
    [No Abstract]   [Full Text] [Related]  

  • 17. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
    Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
    Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
    Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
    Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
    McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
    PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.